Title: Hemodialysis Market by Product Type, Distribution Channel, End User 2023-2028
1Global Hemodialysis Market Research and Forecast
Report 2023-2028
Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3Report Description and Highlights
Report Description
Global Hemodialysis Market Research Report The
latest report by IMARC, titled Hemodialysis
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2023-2028 the
global hemodialysis market size reached US 87.0
Billion in 2022. Hemodialysis is a treatment
option for individuals with end-stage renal
disease (ESRD) or acute kidney injury. It
involves the purification of blood using a
dialysis machine, serving as an artificial
kidney. It primarily removes waste products,
excess fluid, and toxins from the bloodstream,
thereby restoring the body's chemical balance.
During hemodialysis, the patient's blood is
diverted through a dialyzer, a filter-like
component within the dialysis machine. The
dialyzer consists of a semipermeable membrane
that allows the passage of waste products and
excess fluid while retaining vital blood
components. One of the primary advantages of
hemodialysis is its ability to efficiently
eliminate waste products and regulate fluid
balance, providing relief from symptoms
associated with kidney failure. Furthermore, it
can be performed at specialized dialysis centers
or home, offering flexibility and convenience for
patients. In comparison to peritoneal dialysis,
it provides more rapid and effective removal of
toxins from the body. Currently, there are
different types of hemodialysis treatment
available, including conventional hemodialysis
and hemodiafiltration. Request Free Sample
Report https//www.imarcgroup.com/hemodialysis-ma
rket/requestsample
4Report Description and Highlights
Report Description
Global Hemodialysis Market Trends The global
hemodialysis market is primarily influenced by
the rising prevalence of chronic kidney diseases
(CKD) and end-stage renal disease (ESRD) across
the globe. This is further supported by the
increasing geriatric population more susceptible
to such ailments. Moreover, the growing number of
dialysis centers and significant advancements in
hemodialysis technologies, such as the
introduction of high-flux dialyzers and online
hemodiafiltration systems, are boosting the
market growth. The rising healthcare expenditure
and availability of favorable reimbursement
policies for dialysis treatments are also
propelling the market growth. Additionally, the
surging awareness about renal care, the
availability of portable and home hemodialysis
devices, and the growing adoption of telemedicine
for remote monitoring of dialysis patients are
contributing to the market growth. Moreover,
burgeoning investments in research and
development (RD) activities to improve the
efficacy and safety of hemodialysis procedures,
along with the emergence of wearable artificial
kidneys and bioengineered blood vessels, are
providing an impetus to the market growth.
Furthermore, the integration of artificial
intelligence (AI) in hemodialysis machines is
creating a positive outlook for the market. Apart
from this, the rising prevalence of diabetes and
hypertension, the increasing demand for
home-based hemodialysis, and surging mergers and
acquisitions activities among key market players
are favoring the market growth. Looking forward,
the market value is projected to reach US 111.4
Billion by 2028, expanding at a CAGR of 3.8
during 2023-2028.
5Report Description and Highlights
Report Description
- Market Summary Segment Insights
- Hemodialysis Product
- Machines
- Dialyzers
- Others
- Hemodialysis Service
- In-center Services
- Home Services
- Modality Insights Conventional
Hemodialysis Short Daily Hemodialysis
Nocturnal Hemodialysis End User Insights
Hospitals Independent
Dialysis Centres - Others
6Report Description and Highlights
Report Description
Regional Insights Asia Pacific
Europe North America Middle
East and Africa Latin America
7Report Description and Highlights
Report Description
- Competitive Landscape with Key Players
- Baxter International Asahi Kasei Corporation B. Ba
run Melsungen DaVita Cantel Medical Corporation Fr
esenius Medical Care Nipro Corporation Rockwell Me
dical Medivators Toray Medical Company Ltd. Nikkis
o Co. Ltd. - Surni Group
- Gambro
- Satellite Healthcare Inc.
- Renacon Pharma Ltd.
- View Full Report with TOC List of Figure
https//www.imarcgroup.com/hemodialysis-market
8Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
9Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10Report Description and Highlights
Report Description
2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
11 Contact Us